Oxford BioMedica - PDFSEARCH.IO - Document Search Engine

Oxford BioMedica
Results: 5

#	Item
1	Page 1 of 2 Oxford BioMedica Interim Management Statement Oxford, UK – 13 May 2014: Oxford BioMedica plc (LSE: OXB), (“the Company”) the leading gene based biopharmaceutical company, today publishes its interim ma Add to Reading List Source URL: www.oxfordbiomedica.co.uk Language: English - Date: 2014-05-13 02:05:31 Pharmacology ProSavin Sanofi Pharmaceutical industry Cell therapy Biology Oxford BioMedica Pharmaceutical sciences
2	Page 1 of 2 Oxford BioMedica plc Annual General Meeting Oxford, UK – 03 June 2014: Oxford BioMedica ("the Company") (LSE: OXB), the leading genebased biopharmaceutical company, announced today that all resolutions pro Add to Reading List Source URL: www.oxfordbiomedica.co.uk Language: English - Date: 2014-06-03 10:19:23 Business Law Legal terms United Kingdom company law Oxford BioMedica Companies Act Biogen Idec Proxy voting Board of directors Corporations law Private law Business law
3	Page 1 of 2 Oxford BioMedica receives Technology Strategy Board grant for OXB-102 -- £2.2M award will be used to fund a Phase I/II clinical trial of OXB102, an enhanced version of ProSavin®; a gene therapy for the tre Add to Reading List Source URL: www.oxfordbiomedica.co.uk Language: English - Date: 2014-04-30 09:18:04 ProSavin Innovation Biotechnology Gene therapy Technology Strategy Board Biology Medicine Oxford BioMedica
4	Page 1 of 2 !! !! !! Oxford BioMedica provides update on RetinoStat Add to Reading List Source URL: www.oxfordbiomedica.co.uk Language: English - Date: 2014-04-29 03:07:02 Pharmaceutical industry Health Medicine Oxford BioMedica Ranibizumab Macular degeneration
5	OXFORD BIOMEDICA PLC PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2013 Oxford, UK – 10 April 2014: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical c Add to Reading List Source URL: www.oxfordbiomedica.co.uk Language: English - Date: 2014-04-10 02:09:25 Biotechnology Pharmacology TroVax Clinical research Oxford BioMedica Gene therapy Clinical trial Pharmaceutical industry Cell therapy Biology Medicine Science

UPDATE